HCPCS A9595: Piflufolastat F-18, Diagnostic, 1 Millicurie

Learn more about HCPCS code A9595, its documentation and billing requirements, and how to use and code it properly from our short guide.

Use Code

Frequently asked questions

Piflufolastat F-18, marketed as Pylarify®, is a radiopharmaceutical agent used for tumor identification. To elaborate, it is used in positron emission tomography (PET) imaging to detect prostate-specific membrane antigen (PSMA)-positive lesions in men with suspected metastasis who are initial definitive therapy candidates or those with suspected recurrence. It is administered intravenously and aids in identifying prostate cancer metastasis or recurrence, particularly in patients with elevated prostate-specific antigen (PSA) levels.

Yes, PET scan procedures should be reported under the most specific CPT® code for the procedure performed, such as 78815 or 78816, depending on the extent of the scan.

Reimbursement rates vary by payer and geographic location. For specific and additional information, please check each payer's guidelines.